Cargando…
Mild Amnestic Cognitive Impairment and Depressive Symptoms in Autoimmune Encephalitis Associated with Serum Anti-Neurexin-3α Autoantibodies
(1) Background: autoimmune encephalitis associated with neurexin-3α antibodies is a seldom reported disease entity often accompanied by a severe clinical neuropsychiatric syndrome. (2) Method: we report on the case of a 58-year-old man diagnosed with neurexin-3α-associated autoimmune encephalitis re...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224079/ https://www.ncbi.nlm.nih.gov/pubmed/34064006 http://dx.doi.org/10.3390/brainsci11060673 |
_version_ | 1783711820055314432 |
---|---|
author | Hansen, Niels Lange, Claudia Maass, Fabian Hassoun, Lina Bouter, Caroline Stöcker, Winfried Schott, Björn Hendrik Wiltfang, Jens Fitzner, Dirk |
author_facet | Hansen, Niels Lange, Claudia Maass, Fabian Hassoun, Lina Bouter, Caroline Stöcker, Winfried Schott, Björn Hendrik Wiltfang, Jens Fitzner, Dirk |
author_sort | Hansen, Niels |
collection | PubMed |
description | (1) Background: autoimmune encephalitis associated with neurexin-3α antibodies is a seldom reported disease entity often accompanied by a severe clinical neuropsychiatric syndrome. (2) Method: we report on the case of a 58-year-old man diagnosed with neurexin-3α-associated autoimmune encephalitis revealing cognitive decline and depression before the proof of neurexin-3α antibodies. He underwent neuropsychological testing, peripheral blood and cerebrospinal fluid analysis, neuroimaging and electroencephalography. (3) Results: our patient’s main clinical feature was amnestic cognitive decline in combination with depressive symptoms. CSF analysis showed elevated phosphorylated tau protein 181 and positive proof of serum neurexin-3α antibodies in a cell-based assay. An 18F-FDG-PET/CT of the brain initially showed bilateral cerebral hypometabolism prefrontal and parietal, which was absent in follow up. The brain MRI was unremarkable. EEG recordings showed frontotemporal slowing in the theta and delta range. (4) Conclusions: taken together, we assumed autoimmune encephalitis associated with serum neurexin-3α antibodies. To the best of our knowledge, we are the first to report on a predominantly mild clinical manifestation entailing amnestic mild cognitive impairment in addition to depression, thus broadening the clinical spectrum associated with neurexin-3α antibodies. |
format | Online Article Text |
id | pubmed-8224079 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-82240792021-06-25 Mild Amnestic Cognitive Impairment and Depressive Symptoms in Autoimmune Encephalitis Associated with Serum Anti-Neurexin-3α Autoantibodies Hansen, Niels Lange, Claudia Maass, Fabian Hassoun, Lina Bouter, Caroline Stöcker, Winfried Schott, Björn Hendrik Wiltfang, Jens Fitzner, Dirk Brain Sci Case Report (1) Background: autoimmune encephalitis associated with neurexin-3α antibodies is a seldom reported disease entity often accompanied by a severe clinical neuropsychiatric syndrome. (2) Method: we report on the case of a 58-year-old man diagnosed with neurexin-3α-associated autoimmune encephalitis revealing cognitive decline and depression before the proof of neurexin-3α antibodies. He underwent neuropsychological testing, peripheral blood and cerebrospinal fluid analysis, neuroimaging and electroencephalography. (3) Results: our patient’s main clinical feature was amnestic cognitive decline in combination with depressive symptoms. CSF analysis showed elevated phosphorylated tau protein 181 and positive proof of serum neurexin-3α antibodies in a cell-based assay. An 18F-FDG-PET/CT of the brain initially showed bilateral cerebral hypometabolism prefrontal and parietal, which was absent in follow up. The brain MRI was unremarkable. EEG recordings showed frontotemporal slowing in the theta and delta range. (4) Conclusions: taken together, we assumed autoimmune encephalitis associated with serum neurexin-3α antibodies. To the best of our knowledge, we are the first to report on a predominantly mild clinical manifestation entailing amnestic mild cognitive impairment in addition to depression, thus broadening the clinical spectrum associated with neurexin-3α antibodies. MDPI 2021-05-21 /pmc/articles/PMC8224079/ /pubmed/34064006 http://dx.doi.org/10.3390/brainsci11060673 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Case Report Hansen, Niels Lange, Claudia Maass, Fabian Hassoun, Lina Bouter, Caroline Stöcker, Winfried Schott, Björn Hendrik Wiltfang, Jens Fitzner, Dirk Mild Amnestic Cognitive Impairment and Depressive Symptoms in Autoimmune Encephalitis Associated with Serum Anti-Neurexin-3α Autoantibodies |
title | Mild Amnestic Cognitive Impairment and Depressive Symptoms in Autoimmune Encephalitis Associated with Serum Anti-Neurexin-3α Autoantibodies |
title_full | Mild Amnestic Cognitive Impairment and Depressive Symptoms in Autoimmune Encephalitis Associated with Serum Anti-Neurexin-3α Autoantibodies |
title_fullStr | Mild Amnestic Cognitive Impairment and Depressive Symptoms in Autoimmune Encephalitis Associated with Serum Anti-Neurexin-3α Autoantibodies |
title_full_unstemmed | Mild Amnestic Cognitive Impairment and Depressive Symptoms in Autoimmune Encephalitis Associated with Serum Anti-Neurexin-3α Autoantibodies |
title_short | Mild Amnestic Cognitive Impairment and Depressive Symptoms in Autoimmune Encephalitis Associated with Serum Anti-Neurexin-3α Autoantibodies |
title_sort | mild amnestic cognitive impairment and depressive symptoms in autoimmune encephalitis associated with serum anti-neurexin-3α autoantibodies |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224079/ https://www.ncbi.nlm.nih.gov/pubmed/34064006 http://dx.doi.org/10.3390/brainsci11060673 |
work_keys_str_mv | AT hansenniels mildamnesticcognitiveimpairmentanddepressivesymptomsinautoimmuneencephalitisassociatedwithserumantineurexin3aautoantibodies AT langeclaudia mildamnesticcognitiveimpairmentanddepressivesymptomsinautoimmuneencephalitisassociatedwithserumantineurexin3aautoantibodies AT maassfabian mildamnesticcognitiveimpairmentanddepressivesymptomsinautoimmuneencephalitisassociatedwithserumantineurexin3aautoantibodies AT hassounlina mildamnesticcognitiveimpairmentanddepressivesymptomsinautoimmuneencephalitisassociatedwithserumantineurexin3aautoantibodies AT boutercaroline mildamnesticcognitiveimpairmentanddepressivesymptomsinautoimmuneencephalitisassociatedwithserumantineurexin3aautoantibodies AT stockerwinfried mildamnesticcognitiveimpairmentanddepressivesymptomsinautoimmuneencephalitisassociatedwithserumantineurexin3aautoantibodies AT schottbjornhendrik mildamnesticcognitiveimpairmentanddepressivesymptomsinautoimmuneencephalitisassociatedwithserumantineurexin3aautoantibodies AT wiltfangjens mildamnesticcognitiveimpairmentanddepressivesymptomsinautoimmuneencephalitisassociatedwithserumantineurexin3aautoantibodies AT fitznerdirk mildamnesticcognitiveimpairmentanddepressivesymptomsinautoimmuneencephalitisassociatedwithserumantineurexin3aautoantibodies |